meta-analysis | Q815382 |
scholarly article | Q13442814 |
retracted paper | Q45182324 |
P2093 | author name string | Yang Yang | |
Xiao-Lei Wang | |||
Fan-Fan Li | |||
Zhen-Dong Chen | |||
Nian-Fei Wang | |||
Yan-Yan Hong | |||
P2860 | cites work | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex | Q24297574 |
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
Invited commentary: the etiology of lung cancer in men compared with women | Q28383118 | ||
Comparison of two methods to detect publication bias in meta-analysis | Q29617904 | ||
Aberrant promoter methylation of multiple genes in non-small cell lung cancers. | Q31983232 | ||
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | Q33320978 | ||
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients | Q33560360 | ||
Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer | Q33810407 | ||
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer | Q34773458 | ||
Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. | Q36540282 | ||
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer | Q83264629 | ||
Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer | Q83579765 | ||
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum | Q36610297 | ||
Genomic landscape of non-small cell lung cancer in smokers and never-smokers | Q36851245 | ||
Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer | Q37624861 | ||
Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death | Q37624869 | ||
Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray | Q38293385 | ||
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer | Q39669384 | ||
Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells | Q39698112 | ||
Genome-wide DNA methylation profiling of non-small cell lung carcinomas | Q42019243 | ||
Tumoral tissue specific promoter hypermethylation of distinct tumor suppressor genes in a case with nonsmall cell lung carcinoma: a case report | Q42161785 | ||
Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group tr | Q43206162 | ||
Epigenetic down-regulation of death-associated protein kinase in lung cancers. | Q44545571 | ||
Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibility. | Q46027256 | ||
Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? | Q46409679 | ||
RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. | Q51633333 | ||
Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. | Q54506969 | ||
DAP kinase links the control of apoptosis to metastasis | Q59083516 | ||
Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers | Q80556838 | ||
Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: Promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression | Q80880980 | ||
HEGESMA: genome search meta-analysis and heterogeneity testing | Q81849916 | ||
P433 | issue | 6 | |
P304 | page(s) | 6011-6020 | |
P577 | publication date | 2014-06-01 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis | |
P478 | volume | 35 |